ficity. It therefore seems that the common perception of the phenomenon of multidrug transporters as paradoxical and challenging to the basic dogmas of biochemistry has been misdirected : these dogmas are not as strict as they seem. 
result of an ancestral gene duplication and fusion. Each half has a consensus NBD. The mechanism of allosteric activation of the ArsA ATPase has been elucidated by a combination of molecular genetics and biochemical, structural and kinetic analyses. Conformational changes produced by binding of substrates, activator and/or products could be revealed by stopped-flow fluorescence measurements with single-tryptophan derivatives of ArsA. The results demonstrate that the ratelimiting step in the overall reaction is a slow isomerization between two conformations of the enzyme. Allosteric activation increases the rate of this isomerization such that product release becomes rate-limiting, thus accelerating catalysis. ABC transporters, which exhibit similar substrate activation of ATPase activity, can undergo similar conformational changes to overcome a ratelimiting step. Thus the ArsAB pump is a useful model for elucidating mechanistic aspects of the ABC superfamily of transport ATPases.
Abbreviations used: MDR muttidrug resistance P-glycoprotein; NBD, nucleotide-binding domain.
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introduction
The emergence of multi-drug resistance in antimicrobial and cancer chemotherapy is a cause of 0 2000 Biochemical Society concern to patient and physician as well as to the pharmaceutical industry. One of the major mechanisms of drug resistance is the active extrusion of the compounds from the cell, thereby decreasing their concentrations to sub-toxic levels.
In the bacterium Escherichia coli, resistance to toxic oxyanions of arsenic and antimony is conferred by the ars operon of plasmid R773 [l] . T h e ArsAB pump is an arsenite/antimonite-translocating ATPase that is encoded by the arsA and arsB genes of the R773 ars operon (Figure 1 ). T h e 63 kDa ArsA ATPase is the catalytic subunit of the pump. It hydrolyses A T P in the presence of arsenite or antimonite. T h e chemical energy so released is used to extrude arsenite or antimonite out of the cell through the 45 kDa ArsB subunit that forms the oxyanion-translocating pathway [2] . When overexpressed, ArsA can be purified as a soluble ATPase that is allosterically activated by either arsenite or antimonite. T h e 583-residue ArsA ATPase has two homologous A1 and A2 halves of approx. 30 kDa each [3] , connected by a 25-residue linker peptide [4] . Each half has a nucleotide-binding domain (NBD) or the Walker A motif [5] .
T h e ArsAB pump exhibits structural and functional similarity to the human multidrug resistance P-glycoprotein (MDR), which confers resistance to anti-cancer drugs [6] . Both are substrate-dependent ATPases, have two similar consensus NBDs and also have 12 membranespanning a-helices. T h e mechanism by which drugs activate the efflux pumps that confer resistance to those drugs is a major unanswered question in the field of resistance. Understanding bacterial metal-resistance mechanisms can increase our knowledge of the molecular events involved in the efflux-pump-catalysed extrusion of cytotoxic compounds. Here we discuss the relationship between the allosteric domain and NBD of ArsA ATPase, the mechanism of allosteric activation and the proposed reaction scheme for metalloid-stimulated ATPase activity. 
ArsAB pump
The AnAB pump has two subunits: the translocation subunit, AnB, and the catalytic subunit, AnA. AnB has I 2 transmembrane segments and binds ArsA on the cytoplasmic side of the inner membrane. AnA is an ATPase with two homologous halves, Al and A2, each of which has a consensus NBD. The pump detoxifies anenite and antimonite by pumping those oxyanions out of the cells. [8] . T h e arsA gene encodes a protein of 583 residues with two homologous halves, the Nterminal A1 domain (residues 1-288) and the Cterminal A2 domain (residues 3 14-583), connected by a flexible 25-residue linker peptide (residues 289-3 13) ( Figure 2A ). Both the A1 and A2 halves have a consensus NBD ( Figure 2B ). When overexpressed and purified, ArsA demonstrated arsenite-or antimonite-stimulated ATPase activity [9] . Mutations in either A1 or A2 NBD resulted in a loss of resistance, transport and ATPase activity [10, 11] . Genetic suppression results indicated that the two NBDs in ArsA interact [12] . T h e codons for Gly15 in the Nterminal consensus nucleotide-binding sequence and G1y334 in the C-terminal sequence were individually mutated to cysteine codons. Cells expressing an arsA,,,,, mutation retained arsenite resistance, whereas an arsA,,,, mutation resulted in substantial decreases in arsenite resistance, transport and ATPase activity. One suppressor mutant that restored arsenite resistance yielded an A344V substitution. Ala3" is located adjacent to the C-terminal nucleotide-binding sequence. Cells expressing the G15C/A344V double mutant regained arsenite extrusion. These results suggested a spatial proximity of Gly15 and Ala344 and supported a model for interaction of the nucleotide-binding sites in ArsA. T h e alteration of Ala3" to bulkier residues, including Cys, Thr, Pro, Asp, Leu, Phe, Tyr or Arg, also suppressed the G15C substitution: the bulkier the residue, the greater the suppression [13] . In contrast with the effect of residue size at position 344 on arsenite resistance, there was an inverse effect of residue size at position 15. T h e alteration of Gly15 to Ala, Cys, Asp, T y r or Arg resulted in decreased arsenite resistance ; a G15R substitution produced the least resistance. Again, the G15R phenotype could be effectively rescued by the introduction of a larger residue at position 344. These results are consistent with a physical interaction of the two NBDs and indicate that the geometry at the interface between A1 and A2 NBDs impose steric constraints on allowable residues in that interface. Mg2+ is required for ArsA ATPase activity [ 141. Conformational changes at the nucleotidebinding site as evidenced by the increase in intrinsic tryptophan fluorescence was observed only on the addition of MgATP, suggesting that Mg2+ binds to ArsA as a complex with A T P [15] . It has been shown that the aspartic residue in ATP-and GTP-binding proteins serve as Mg2+ ligand ( Figure 2B) . A sequence alignment of ArsA with other enzymes such as nitrogenase iron protein (NifH) [16] , RecA [17] and Ras p21 [18] suggested that Aspg5 in the conserved pair of residues A~p '~-P r o~~ might be a putative Mg2+ ligand. T o examine the role of Asp", mutants were constructed in which Aspg5 was changed to Glu, Asn or Ala [19] . Cells expressing these mutated arsA genes lost arsenite resistance, to varying degrees. Purified D45A and D45N ArsAs were inactive, whereas the D45E enzyme exhibited approx. 5 yo of the wild-type activity with an approx. 5-fold decrease in affinity for Mg2+. These and additional experiments supported the role of Aspg5 as a Mg2+ ligand [ 191.
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Allosteric domain
Antimonite or arsenite allosterically activates ArsA ATPase activity. In absence of the metalloids, ArsA has a low level of ATPase activity. Arsenite stimulates A T P hydrolysis by 3-5-fold, whereas a 10-20-fold stimulation is observed with antimonite as the activator. All other oxyanions tested had no effect on ATPase activity [14] . However, the results suggest that arsenite or antimonite activates ArsA by interacting as the trivalent soft metals As( I I I) or Sb( I I I) through covalent bonding with cysteine thiolates of the protein rather than by binding as oxyanions to an anion-binding site. First, thiol-modifying reagents such as methyl methanethiosulphonate ('MMTS') were shown to inhibit ArsA ATPase activity, suggesting the involvement of cysteine residues in catalysis [20] . Secondly, mutagenesis of cysteine codons shows the direct involvement of thiolates in allosteric activation. ArsA has four cysteine residues, CysZ6, Cys113, C~S "~ and Cys422 (Figure 2A ). Each cysteine residue was altered to a serine. C26S ArsA showed identical properties to those of the wild-type enzyme, suggesting that CysZ6 is not involved in activation. Cells expressing the other three mutations were sensitive to arsenite and antimonite. T h e purified C113S, C172S and C422S enzymes each exhibited a similar affinity for A T P to the wild-type enzyme. However, the concentration of Sb( I I I) or As( I I I) required for activation was substantially increased, reflecting a decrease in affinity for the metalloid in the three altered enzymes. Limited trypsin-digestion experiments also supported the idea that the activator-binding site of C113S, C172S and C422S was modified. These results suggested a mechanism of allosteric activation of ArsA in which Sb(II1) or As(II1) forms a tri-coordinate complex with the cysteine thiolates 113, 172 and 422.
Although these three cysteine residues are located at different regions in the primary structure, the results indicate that they must come close together in the tertiary structure to interact with either As(II1) or Sb(II1). T o determine the distance between cysteine residues, wild-type ArsA and ArsA proteins with Cys-rSer substitutions were treated with the bifunctional alkylating agent dibromobimane [21] . This reagent reacts with thiol pairs residing within 3-6 A of each other to form a fluorescent adduct. ArsAs containing any two of the three essential cysteine residues (Cys*13, C Y S '~~ and formed fluorescent adducts. Proteins in which two of the three essential cysteine residues were substituted did not form fluorescent adducts. These results demonstrate that Cys113, C Y S '~~ and Cysd2' are in close proximity to each other in the native enzyme such that As(II1) or Sb(II1) can interact with these three residues in a trigonal pyramidal geometry, forming a novel soft metal-thiol cage. ArsA is the only known example of an enzyme that requires As(II1) or Sb(II1) for its activity.
Hinge region
T h e sequence of ArsA indicated that the two NBDs are 'hinged ' by a 25-residue linker peptide in the region of 289-31 3. T h e requirement for this linker sequence was examined by the mutagenic insertion of five glycine residues or by the deletion of 5, 10, 15 or 23 residues [4] . Cells expressing an arsA gene with a five-residue insertion between codons 301 and 302 exhibited similar resistance to the wild type. Cells expressing an arsA gene with any of the 5-codon deletions (295-299,300-304 or 305-309) or a 10-codon deletion (297-306) exhibited slightly decreased resistance. T h e deletion of 15 codons (295-309) decreased the resistance further; a 23 codon deletion (291-313) resulted in the least resistance. Each of the altered ArsAs was purified. T h e enzyme with the five-residue insertion had the same affinity for A T P and Sb(II1) as the wild-type enzyme. Shortening the linker by five residues in each of three different positions decreased the affinity of the enzymes for A T P 10-20-fold. T h e effect on allosteric activation was even more marked : the concentration of Sb( 111) required for half-maximal stimulation increased 15-300-fold. Decreasing the length of the linker by 10 or more residues eliminated activation, suggesting that the allosteric site could not form in proteins with shortened linkers. T h e sensitivity of ArsAs with altered linkers to trypsin was also examined. In the absence of A T P and metalloid, the initial cleavage by trypsin is in the linker at Arg2", producing an N-terminal 31 kDa A1 fragment (residues 1-290) that is resistant to further digestion, and a C-terminal 32 kDa A2 fragment that is rapidly cleaved to small peptides [22] . Sb(II1) alone has no effect on trypsin digestion, and A T P alone decreases the rate of production of smaller fragments. T h e binding of both A T P and Sb( I I I) results in protection of the trypsin sites on A2, most probably because the trypsin-sensitive residues are sequestered at the interface of A1 and A2 as the halves are brought together. T h e wildtype pattern of peptides was reproducibly produced in the ArsA with the 5-glycine insertion, the three 5-residue deletions and the 10-residue deletion. T h e enzymes with the 15-and 23-residue deletions exhibited similar trypsin sensitivity to the wild type in the absence of ligands. In contrast, those two proteins showed no synergistic protection by A T P and Sb(III), indicating that shorter linkers prevented the formation of the correct interface between A1 and A2. These results indicate that, although the linker is not required for catalysis, it facilitates the ability of the enzyme to form the A1/A2 interface. Formation of the As(II1)-thiol structure pulls the two halves of the enzyme together. This brings the nucleotidebinding sites in close proximity to each other, facilitating catalysis.
A similar role has been proposed for the 75-residue linker connecting the two homologous halves of the human MDR. A 34-residue segment of the linker could be replaced by a 17-residue flexible sequence without functional loss, suggesting that length and flexibility, but not specific sequence, might be sufficient for the two halves of the P-glycoprotein to interact [23] . It was proposed that the function of the linker is to facilitate the proper interaction of the two NBDs.
Although both the A1 and A2 sites bind nucleotides, it is not known whether both NBDs are catalytic. Although it is relatively certain that the A1 NBD hydrolyses ATP, the current results do not distinguish between a hydrolytic and a regulatory role for the A2 NBD. In the absence of arsenite or antimonite the A1 NBD binds A T P but the A2 NBD does not [22] . T h e results suggest that the A1 NBD is a high-affinity binding site but that the A2 site can bind A T P only when the enzyme is activated. Mutations in either NBD eliminate the As(III)/Sb( 111)-activated hydrolysis [10, 11] . However, the effect of mutation on the basal, unactivated rate was quite different. A substitution in the A1 NBD eliminated all activity, both basal and activated, whereas a substitution in the A2 NBD resulted in the retention of basal activity only [24] . This result suggests that the A1 NBD can hydrolyse A T P by itself but at a low basal rate (essentially single-site catalysis) but the binding of As(II1) or Sb(II1) accelerates catalysis by producing multisite catalysis at both sites [24] .
Signal transduction domain
How does the binding of As(II1) or Sb(II1) at the allosteric domain produce multisite catalysis ? There must be a flow of information from the metalloid-binding site to the catalytic sites. Transduction of the signal between these two domains has been shown to be mediated by a 12- In the Trp15' ArsA all the other three tryptophan residues were changed to tyrosine by site-directed mutagenesis, whereas in the Trp14' protein all native tryptophan residues were replaced by tyrosine, and Phe14' was modified to tryptophan. In the absence of substrate or activator, the emission spectrum of the fluorescence of the tryptophan at the C-terminal end (Trp15') indicated a relatively hydrophilic environment for this residue. On the addition of MgATP, an increase in intrinsic tryptophan fluorescence with a blue shift of the maximum emission wavelength was observed, indicating the movement of Trp15' into a less polar environment. This fluorescence response was not observed in the presence of MgADP or with non-hydrolysable A T P analogues. Additionally, the fluorescence change was well correlated with the rate of A T P hydrolysis, suggesting that Trp15' became less solventaccessible only during the hydrolysis of ATP. T h e subsequent addition of Sb( 111) or As( 111) rapidly quenched the ATP-enhanced fluorescence of Trp"'. Because the metalloids increase the rate of catalysis, the results suggest a link between the allosteric transition and the change in environment of the DTAP domain. In comparison, the emission spectrum of Trp14' ArsA in the absence of ligands suggested the location of Trp141 in a relatively non-polar environment. T h e addition of MgADP decreased the fluorescence intensity, with a red shift of the maximum emission wavelength. T h e addition of MgATP slowly decreased Trp141 fluorescence in a manner correlated with product formation, suggesting that the environment of Trp141 is sensitive only to MgADP binding. These results suggest that during A T P hydrolysis the C-terminal end of the conserved DTAP domain moves into a less polar environment, whereas the N-terminal end moves into a more hydrophilic environment as product is formed. Thus the allosteric and catalytic domains are conformationally connected to each other by movement in the signal transduction domains.
Reaction mechanism of the ArsA ATPase
What are the molecular steps in ArsA activation and catalysis ? T h e kinetic mechanism of ArsA ATPase reaction has been studied by stoppedflow fluorescence experiments. The singletryptophan-containing Trp15' ArsA was used to elucidate the elementary steps of the ATPase mechanism. In the unactivated, basal hydrolytic reaction, the binding and hydrolysis of MgATP are a multistep process in which the rate-limiting step is an isomerization between two different conformational forms of ArsA [26]. This isomerization occurs after the release of the products ADP and Pi and involves the return of the ArsA to its original conformation, which can bind another MgATP. This rate-limiting conformational change is reminiscent of the El-E2 transition in P-type ATPases [27] .
A transient kinetics approach was used to investigate the kinetics of ternary complex formation that led to an enhancement in the ATPase activity in the allosterically activated enzyme (A. R. Walmsley, T. Zhou, M. I. BorgesWalmsley and B. P. Rosen, unpublished work) .
These studies indicated that ArsA exists in at least two conformational forms that differ in their ligand binding affinities : A T P favours one form of ArsA and antimonite the other. T h e slow transition between these two conformational forms is rate-limiting for the ArsA-MgATP-As/Sb( 111) ternary complex formation, leading to a lag in attaining maximal steady-state activity. As(II1) or Sb( I I I) enhances the steady-state ATPase activity by inducing rapid product release, allowing ArsA to adopt a conformation that can bind MgATP in the next catalytic cycle. In the presence of the activators, ArsA avoids the rate-limiting isomer-ization at the end of the ATPase reaction; A T P hydrolysis then becomes rate-limiting for the reaction.
Conclusions
T h e mechanism of allosteric activation of the ArsA ATPase has been discussed at the molecular level. Allosteric activation involves the interaction of As(III)/Sb(III) with Cys113 and C Y S "~ in the A1 domain and with Cys422 in the A2 domain. T h e novel soft metal-thiol cage thus formed brings the two domains close to each other; the two NBDs interact to form an interface, thereby accelerating catalysis. In the absence of the activator the ratelimiting step is the isomerization between different conformational forms of ArsA. Binding of the allosteric activator increases the rate of movement of the enzyme through this conformation, accelerating catalysis. We propose that similar conformational changes are rate-limiting in the mechanism of ATP-binding cassette (' ABC ') transporters.
